Nanobac Pharmaceuticals
(OTC) NNBP
Nanobac Pharmaceuticals Financials at a Glance
Market Cap
$200
Revenue (TTM)
$17.62K
Net Income (TTM)
$6.58M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Price
$0.00
Volume
10,000
Open
$0.00
Price
$0.00
Volume
10,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Price
$0.00
Volume
10,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
NNBP News
NNBP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nanobac Pharmaceuticals
NNBP Financials
Key Financial Metrics (TTM)
Gross Margin
18%
Operating Margin
279%
Net Income Margin
-373%
Return on Equity
0%
Return on Capital
10%
Return on Assets
-91%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$200.00
Shares Outstanding
249.51M
Volume
10.00K
Short Interest
0.00%
Avg. Volume
9.35K
Financials (TTM)
Gross Profit
$3.10K
Operating Income
$4.91M
EBITDA
$5.93M
Operating Cash Flow
$910.89K
Capital Expenditure
$1.53K
Free Cash Flow
$912.42K
Cash & ST Invst.
$3.93K
Total Debt
$4.12M
Nanobac Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$4.37K
+86.6%
Gross Profit
$678.00
-58.7%
Gross Margin
15.52%
N/A
Market Cap
$200.00
N/A
Market Cap/Employee
$200.00
N/A
Employees
1
N/A
Net Income
$1.17M
+37.4%
EBITDA
$1.03M
+40.0%
Quarterly Fundamentals
Net Cash
$4.12M
+22.7%
Accounts Receivable
$1.87K
+164.0%
Inventory
$10.30K
-84.5%
Long Term Debt
$0.00
N/A
Short Term Debt
$4.12M
-23.2%
Return on Assets
-91.08%
N/A
Return on Invested Capital
10.36%
N/A
Free Cash Flow
$110.32K
+83.6%
Operating Cash Flow
$110.32K
+83.5%